Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,152,200
Avg Vol 13,303,164
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 100%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. The company engages in identifying small molecules that inhibit or express NR2F6, leading to immune cell activation for oncology applications and immune cell suppression for autoimmune diseases. It also develops several products: HemaXellarate, a cellular therapeutic product derived from autologous stromal vascular fraction from adipose tissue; dCellVax, an autologous dendritic cell treate...

Industry: Biotechnology
Sector: Healthcare
Phone: 619 722 5505
Address:
8697 La Mesa Boulevard, Suite C #107, La Mesa, United States
LoveMonsterCG
LoveMonsterCG May. 19 at 8:11 PM
$RGBP Closing Chart Common Shares 5/19/2026... $0.0005 +.0001 +25.00% Vol 1,152,200 Open .0004 High .0005 Low .0004 Close .0005 Best wishes everyone for 2026! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 19 at 8:11 PM
$RGBP $RGBPP Closing Chart Preferred Shares 5/19/2026... $0.005 +.0011 +28.20% Vol 90,401 Open .0031 High .0069 Low .0031 Close .005 Best wishes everyone for 2026! 😊🤙🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 18 at 11:33 PM
$RGBP Closing Chart Common Shares 5/18/2026... $0.0004 Unchanged Vol 3,630,156 Volume has tapered off for now. Hopefully share conversions for all of the company's existing convertible debts are close to completion. Best wishes everyone for 2026! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 18 at 11:33 PM
$RGBP $RGBPP Closing Chart Preferred Shares 5/18/2026... $0.0039 -.0021 -35.00% Vol 125,398 Open .007 High .007 Low .0034 Close .0039 Best wishes everyone for 2026! 😊🤙🍀
0 · Reply
BBAR_Boltar
BBAR_Boltar May. 18 at 11:26 PM
$RGBP Any shareholder actually want to do something about this debt case? Contact the SEC with this information. This will be long and I will post this is a series of replies to this post: Overview of the Fraudulent Scheme: This complaint concerns an ongoing pattern of self-dealing, breach of fiduciary duty, and potentially fraudulent market manipulation orchestrated by Regen Biopharma, Inc. (RGBP) CEO David Koos. The scheme involves the deliberate creation and assignment of insider debt to third parties for the purpose of evading SEC registration requirements, engineering artificial litigation, and dumping massive volumes of newly minted, unrestricted shares onto public retail investors.
1 · Reply
BBAR_Boltar
BBAR_Boltar May. 18 at 10:49 PM
$RGBP He is not worried about the lawsuit because it was known it was going to take place at the time he sold them his debt. The only way the firm would be able to recoup the funds from RGBP is to act against RGBP. And why would he worry about another 400% dilution when he's already done that himself in the past 2 years? For sure, it's looking like an exit strategy as much of this debt owed to him was owed to him for MANY YEARS. Why now suddenly seek a way to cash in now? Connect the dots, 2 missed Emerging Markets Conference, and now cashing in on years old debt. Only someone like LM wouldn't see what's happening. @DarthSally
0 · Reply
DarthSally
DarthSally May. 17 at 2:22 PM
$RGBP so I just read Bay’s latest comments on X. And I’m able to follow Boltar‘s train a thought. And naturally Trippin has good insight with facts. Here’s what I get out of all that. Koos is looking for an exit strategy. The ends justify the means type of thing. He doesn’t seem to be worried about the lawsuit. Maybe it’s all orchestrated like other’s have suggested. It just all seems too convenient for him, especially with nothing in the pipeline to look forward to I think he’s going to take his ball and go home while we’re all standing there on the field looking dumbfounded. 
3 · Reply
TrippinStones
TrippinStones May. 17 at 12:02 AM
$RGBP Remember I told you months ago Harry has bailed on us? This is why: "Plaintiff has not named any Doe Defendant in its Complaint as all obligations originate from Defendant RGBP the corporate entity. However, to the extent other individuals or other entities are determined to be responsible through discovery, the Plaintiff reserves the right to add those parties as defendants to the Complaint by amendment thereto." **** A Doe defendant is a temporary placeholder (such as John or Jane Doe) used in a legal complaint when the true identity of a person or entity responsible for a wrong is unknown at the time the lawsuit is filed. A Doe defendant allows a lawsuit to proceed immediately while still giving the Plaintiff opportunity to add others as Defendants. 🧚
0 · Reply
BBAR_Boltar
BBAR_Boltar May. 16 at 3:31 PM
$RGBP What Koos says vs the REALITY of what Koos does! -- Says, "we're looking to license our IP, and we have 'some interest' in it". --- What did he do since then instead? -- "Hey, I have this idea, I'll sell you my debt, you sue my company and I pay you in shares worth a lot more, and we both profit, diluting shareholders greater than ever". --- If you can't see this, you have no one but yourself to blame when this falls another 90%... and IT WILL!
2 · Reply
Billdog78
Billdog78 May. 16 at 2:05 PM
$RGBP suckers!!!!
1 · Reply
Latest News on RGBP
No data available.
LoveMonsterCG
LoveMonsterCG May. 19 at 8:11 PM
$RGBP Closing Chart Common Shares 5/19/2026... $0.0005 +.0001 +25.00% Vol 1,152,200 Open .0004 High .0005 Low .0004 Close .0005 Best wishes everyone for 2026! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 19 at 8:11 PM
$RGBP $RGBPP Closing Chart Preferred Shares 5/19/2026... $0.005 +.0011 +28.20% Vol 90,401 Open .0031 High .0069 Low .0031 Close .005 Best wishes everyone for 2026! 😊🤙🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 18 at 11:33 PM
$RGBP Closing Chart Common Shares 5/18/2026... $0.0004 Unchanged Vol 3,630,156 Volume has tapered off for now. Hopefully share conversions for all of the company's existing convertible debts are close to completion. Best wishes everyone for 2026! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 18 at 11:33 PM
$RGBP $RGBPP Closing Chart Preferred Shares 5/18/2026... $0.0039 -.0021 -35.00% Vol 125,398 Open .007 High .007 Low .0034 Close .0039 Best wishes everyone for 2026! 😊🤙🍀
0 · Reply
BBAR_Boltar
BBAR_Boltar May. 18 at 11:26 PM
$RGBP Any shareholder actually want to do something about this debt case? Contact the SEC with this information. This will be long and I will post this is a series of replies to this post: Overview of the Fraudulent Scheme: This complaint concerns an ongoing pattern of self-dealing, breach of fiduciary duty, and potentially fraudulent market manipulation orchestrated by Regen Biopharma, Inc. (RGBP) CEO David Koos. The scheme involves the deliberate creation and assignment of insider debt to third parties for the purpose of evading SEC registration requirements, engineering artificial litigation, and dumping massive volumes of newly minted, unrestricted shares onto public retail investors.
1 · Reply
BBAR_Boltar
BBAR_Boltar May. 18 at 10:49 PM
$RGBP He is not worried about the lawsuit because it was known it was going to take place at the time he sold them his debt. The only way the firm would be able to recoup the funds from RGBP is to act against RGBP. And why would he worry about another 400% dilution when he's already done that himself in the past 2 years? For sure, it's looking like an exit strategy as much of this debt owed to him was owed to him for MANY YEARS. Why now suddenly seek a way to cash in now? Connect the dots, 2 missed Emerging Markets Conference, and now cashing in on years old debt. Only someone like LM wouldn't see what's happening. @DarthSally
0 · Reply
DarthSally
DarthSally May. 17 at 2:22 PM
$RGBP so I just read Bay’s latest comments on X. And I’m able to follow Boltar‘s train a thought. And naturally Trippin has good insight with facts. Here’s what I get out of all that. Koos is looking for an exit strategy. The ends justify the means type of thing. He doesn’t seem to be worried about the lawsuit. Maybe it’s all orchestrated like other’s have suggested. It just all seems too convenient for him, especially with nothing in the pipeline to look forward to I think he’s going to take his ball and go home while we’re all standing there on the field looking dumbfounded. 
3 · Reply
TrippinStones
TrippinStones May. 17 at 12:02 AM
$RGBP Remember I told you months ago Harry has bailed on us? This is why: "Plaintiff has not named any Doe Defendant in its Complaint as all obligations originate from Defendant RGBP the corporate entity. However, to the extent other individuals or other entities are determined to be responsible through discovery, the Plaintiff reserves the right to add those parties as defendants to the Complaint by amendment thereto." **** A Doe defendant is a temporary placeholder (such as John or Jane Doe) used in a legal complaint when the true identity of a person or entity responsible for a wrong is unknown at the time the lawsuit is filed. A Doe defendant allows a lawsuit to proceed immediately while still giving the Plaintiff opportunity to add others as Defendants. 🧚
0 · Reply
BBAR_Boltar
BBAR_Boltar May. 16 at 3:31 PM
$RGBP What Koos says vs the REALITY of what Koos does! -- Says, "we're looking to license our IP, and we have 'some interest' in it". --- What did he do since then instead? -- "Hey, I have this idea, I'll sell you my debt, you sue my company and I pay you in shares worth a lot more, and we both profit, diluting shareholders greater than ever". --- If you can't see this, you have no one but yourself to blame when this falls another 90%... and IT WILL!
2 · Reply
Billdog78
Billdog78 May. 16 at 2:05 PM
$RGBP suckers!!!!
1 · Reply
BBAR_Boltar
BBAR_Boltar May. 16 at 1:29 PM
$RGBP Koos-Trillium lawsuit deal is a way for Koos to get cash FAST for his debt! If he had issued himself the shares to pay off his own debt, they'd have to be restricted, and he couldn't sell them for a year. So instead he made deal with Trillium to sell the debt to them, and HE gets CASH from them, NOW. Then he settles the lawsuit and issues Trillium the shares. Those shares can be sold by Trillium immediately. Koos isn't stupid. He doesn't want to issue himself shares and then wait a year while the stock falls another 90% and then sell. This is yet another way for any reasonable person to know that Koos is himself telling you RGBP is a scam! --- The only thing I am waiting for is to read how @LoveMonsterCG spins this as not so bad!
1 · Reply
BBAR_Boltar
BBAR_Boltar May. 16 at 1:11 PM
$RGBP Classic hilarious understatement from our resident Warren Buffet, @LoveMonsterCG ---- " I don't always understand how things work in the business world"". Gee, really? Surprising!
0 · Reply
TrippinStones
TrippinStones May. 16 at 6:54 AM
$RGBP LM, Did you know that it is impossible to be both a defendant and plaintiff in a lawsuit? Koos is not a plaintiff. He is however gathering cash through this. He sold debt that he owes himself. Think you're going to see a little bit of double dipping. He made money on selling that debt to Trillium and now when he dumps a billion shares into the market this fall and the company goes bankrupt, he will have already paid himself. These debts include: $37,485.00 due to Bostonia Partners, Inc.; $84,110.00 due to BST Partners, Inc; $83,461.00 due to David Koos And whatever debt Trillium bought from Zander. 🧚
1 · Reply
LoveMonsterCG
LoveMonsterCG May. 16 at 4:03 AM
$RGBP Folks, I did more of a deep dive into finding more information about this lawsuit that's been filed by Trillium Partners LP vs Regen BioPharma, and I found the document which outlines the complaint for the civil lawsuit. Here is the link to it, if you can't see the screenshot... https://unicourt.com/case/ca-sd-casebja880c117b7a8-1900323 But this is really peculiar when you read it. It looks like David Koos actually authorized and approved Trillium Partners to file this lawsuit with the claims against Regen BioPharma on his behalf. David Koos himself appears to be one of the claimants represented by Trillium Partners as the plaintiff in the case. I don't always understand how things work in the business world, but this seems really bizarre. All the claimants in this case who are seeking payment from Regen BioPharma seem to be entities and persons who have business ties and interest to Koos, along with Koos being a claimant in the case himself. So, I guess it would be easy for him to arrange for a settlement. 🤷‍♂️
1 · Reply
LoveMonsterCG
LoveMonsterCG May. 16 at 2:33 AM
$RGBP Share Structure Update Common Shares 5/15/2026... Looks like we got a little break from more diluted shares being issued for this week's update. There were no changes to the "Outstanding Shares" to report for this week. There were no changes to the "Restricted Shares". There were no changes to the "Unrestricted Shares". The only change to report on was, there were 50,000,000 shares added to shares being "Held at DTC". Most likely those are the shares that were issued as unrestricted shares on last week's update. And now they are active and available to trade in the market by whoever is holding them.
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 16 at 2:33 AM
$RGBP Share Structure Update Preferred Shares 5/15/2026... There were no changes to the Outstanding Shares for this week's update. There were no changes to the Restricted or Unrestricted Shares. And there were no changes to shares being Held at DTC.
0 · Reply
TrippinStones
TrippinStones May. 16 at 12:57 AM
$RGBP Here's the thing, if Trillium wanted the shares this woulda been done already. They don't buy debt to get shares. Open market is for that. They BOUGHT the debt amount to collect it plus whatever else the Court decides. Anyone ever hear of Treble Awards? That's TRIPLE THE JUDGEMENT for egregious actions. Willfully neglected disclosures fall under such. The 'negotiations' could only be to reduce such. So maybe it's only $800 K Award. Given the current total destruction of both his IPs reputation and his personal/business reputation, I'm not sure koozeroo can even get a convertible note to cover. That's when you're going to see bankruptcy and DELISTING to the Expert Market with a Court Appointed Controller. It actually could happen within weeks to just a few months. Koozeroo would lose every single share. My personal hope is Trillium takes the whole business and sells it to someone who could manage to get at least 1 IP licensed. Because right now, NO ONE WILL WORK WITH DAVID KOOS. 🧚
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 15 at 8:33 PM
$RGBP Closing Chart Common Shares 5/15/2026... $0.0004 Unchanged Vol 10,562,959 Open .0004 High .0004 Low .0004 Close .0004 Have a nice weekend everyone! Best wishes for 2026! 😊🙏🍀
0 · Reply
LoveMonsterCG
LoveMonsterCG May. 15 at 8:33 PM
$RGBP $RGBPP Closing Chart Preferred Shares 5/15/2026... $0.006 +.001 +20.00% Vol 13,113 Open .0035 High .006 Low .0035 Close .006 Best wishes everyone for 2026! 😊🤙🍀
0 · Reply
BBAR_Boltar
BBAR_Boltar May. 15 at 12:02 PM
$RGBP As usual, @LoveMonsterCG is uninformed when he dismisses the lawsuit as no big deal. (just like when he just said 3 months ago that anyone that said RGBP would be trading in the trips was crazy) Actually, Trillium has a track record of getting more dollar value in their settlement than the value of the debt!!! Trillium Lawsuit History: --- Endonovo Therapeutics (2024) $2.9 million in shares at a 50% discount to market price to retire outstanding debt. Pacific Ventures Group (2023). Settled $6.03 million in debt in exchange for roughly $9.28 million worth of shares (a 35% discount). --- Looking forward to RGBP giving more than half a million dollars worth of RGBP shares to settle this! Don't worry, just listen to LM! Things will be fine!
1 · Reply
TrippinStones
TrippinStones May. 15 at 1:34 AM
$RGBP Who is Trillium Partners, LP? They buy debt from FAILING companies. I cannot emphasize this enough: THEY ARE NOT SOMEONE YOU WANT ON YOUR QUARTERLY REPORT! THERE IS NO UPSIDE OR POSITIVE SPIN. THEY WILL GET THEIR MONEY. AND THEY WILL CAUSE KOOS TO TAKE OUT ANOTHER CONVERTIBLE LOAN WITH MORE UNACCOUNTED-FOR DILUTION AND GO FURTHER INTO DEBT. Here's their most recent lawsuit victims:
0 · Reply
TrippinStones
TrippinStones May. 14 at 11:45 PM
$RGBP RGBP State of Chaos: Pending litigation and control weaknesses: A California complaint seeks $398,740 plus fees, and management concludes disclosure controls and procedures were ineffective, ADDING LEGAL AND GOVERNANCE RISK. *Severe liquidity risk: Cash was $271 March 31, 2026, with working capital deficit of about $5.3M and an accumulated deficit of $21.7M *High leverage to Conv debt and derivatives: Convertible notes payable (net) were $817,717 and derivative liability was $1,278,763 with legacy notes on steep discount terms pressuring equity *Extreme dilution from equity issuance: 232,272,777 common shares were issued in six months to settle $138,072 of principal, $13,630 of interest, and $20,500 of fees, plus 11,111,111 shares for $50,000 cash and 160,519,051 add'l shares after qtr end *Non-cash drives reported profit: Net income of $991,927 for the qtr and $24,074 for 6 mo is primarily due to derivative income from revaluing liabilities. Core ops generated increasing losses. 🧚
0 · Reply